Atria Wealth Solutions’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.07M | Sell |
10,036
-12,074
| -55% | -$1.29M | 0.02% | 610 |
|
2025
Q1 | $2.23M | Buy |
22,110
+4,145
| +23% | +$418K | 0.03% | 591 |
|
2024
Q4 | $1.6M | Buy |
17,965
+6,487
| +57% | +$579K | 0.02% | 721 |
|
2024
Q3 | $962K | Sell |
11,478
-577
| -5% | -$48.4K | 0.01% | 923 |
|
2024
Q2 | $928K | Sell |
12,055
-605
| -5% | -$46.6K | 0.01% | 920 |
|
2024
Q1 | $867K | Buy |
12,660
+1,176
| +10% | +$80.5K | 0.01% | 970 |
|
2023
Q4 | $664K | Sell |
11,484
-274
| -2% | -$15.8K | 0.01% | 1056 |
|
2023
Q3 | $621K | Buy |
11,758
+6,316
| +116% | +$333K | 0.01% | 1027 |
|
2023
Q2 | $294K | Sell |
5,442
-1,148
| -17% | -$62.1K | ﹤0.01% | 1452 |
|
2023
Q1 | $330K | Buy |
6,590
+1,376
| +26% | +$68.8K | ﹤0.01% | 1353 |
|
2022
Q4 | $241K | Buy |
5,214
+21
| +0.4% | +$972 | ﹤0.01% | 1483 |
|
2022
Q3 | $201K | Buy |
+5,193
| New | +$201K | ﹤0.01% | 1548 |
|